Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis

por Wu, J.J., Kavanaugh, A., Lebwohl, M.G., Gniadecki, R., Merola, J.F.
Publicado 2022

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

por Merola, J.F., Ghislain, P.‐D., Dauendorffer, J.N., Potts Bleakman, A., Brnabic, A.J.M., Burge, R., Riedl, E.
Publicado 2020

Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire

por Merola, J F, Nyberg, F, Furukawa, F, Goodfield, M J, Hasegawa, M, Marinovic, B, Szepietowski, J, Dutz, J, Werth, V P
Publicado 2015

Ixekizumab provides persistent improvements in health‐related quality of life and the sexual impact associated with moderate‐to‐severe genital psoriasis in adult patients during a...

por Ryan, C., Guenther, L., Foley, P., Weisman, J., Burge, R.T., Gallo, G., See, K., McKean‐Matthews, M., Bertram, C.C., Merola, J.F.
Publicado 2021

Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health‐related quality of life from two randomized phase 3 studies

por Merola, J.F., Papp, K.A., Nash, P., Gratacós, J., Boehncke, W.H., Thaçi, D., Graham, D., Hsu, M‐A., Wang, C., Wu, J., Young, P.
Publicado 2020

Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate‐to‐severe plaque psoriasis: results from EXCEED, a randomized, double‐blind hea...

por Gottlieb, A.B., Merola, J.F., Reich, K., Behrens, F., Nash, P., Griffiths, C.E.M., Bao, W., Pellet, P., Pricop, L., McInnes, I.B.
Publicado 2021